How is Inflammatory Breast Cancer Treated?Inflammatory breast cancer is an aggressive cancer that can grow and spread quickly. If the inflammatory cancer has not spread beyond the breast, a mastectomy (removal of the entire breast) may be performed to remove the tumor. However, because inflammatory breast cancer involves lymphatic vessels of the skin, mastectomy can increase the chances for the cancer to recur (since the skin is stitched together after mastectomy). Therefore, other treatment options (most commonly, chemotherapy) are usually considered before surgery. Chemotherapy is treatment with anti-cancer drugs. Chemotherapy is often administered to inflammatory breast cancer patients before local treatment (such as mastectomy or radiation). One common regimen of chemotherapy used to treat inflammatory breast cancer patients is CAF (cyclophosphamide, doxorubicin, and fluorouracil). Researchers are also investigating whether high-dose chemotherapy is effective for treating inflammatory breast cancer. Because high dose chemotherapy causes damage to bone marrow cells, a bone marrow transplant or blood stem cell transplantation may be necessary. After surgery, patients with inflammatory breast cancer are usually treated with additional chemotherapy followed by radiation therapy to the chest wall. What is the Prognosis for Inflammatory Breast Cancer?Because inflammatory breast cancer is an advanced cancer, it has been associated with a poor prognosis (expected outcome). Past statistics have shown the average survival rate of inflammatory breast cancer to be approximately 18 months. However, recent studies have shown that advancements in treatment may help to extend the survival time for women with inflammatory breast cancer. Using chemotherapy, surgery (mastectomy), and radiation, the average five-year survival rate is currently 40%. Physicians are hopeful that advances in treatment will continue to improve the prognosis for women diagnosed with inflammatory breast cancer. Additional Resources and References
Updated: September 12, 2007 |
||
Imaginis.com suscribes to the HONcode principles of the Health on the Net Foundation.
Copyright 1997-2009 Imaginis Corporation. All rights reserved. Imaginis® is a registered service mark of Imaginis Corporation, a health services company. All other trademarks and copyrights are property of their respective owners. Note: Use of this online service is subject to the disclaimer and the terms and conditions contained herein. Information found within the Imaginis.com website or in other sites linked to from Imaginis.com is provided for educational purposes only and is not intended to be used as a substitute for diagnosis and treatment by a medical doctor. Imaginis does not endorse and has no responsibility for the content of any other sites listed on Imaginis.com, and provides links and references merely as a convenience to its users. Seek immediate medical attention if your condition is urgent. Imaginis - The Breast Cancer Resource